Magnetic resonance imaging for the detection of myocardial fibrosis in scleroderma [25]

New England Journal of Medicine

Volumn 354, Issue 20, 2006, Pages 2194-2196

  Plastiras, Sotiris C ^a   Kelekis, Nikolaos ^a   Tzelepis, George E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMYLOIDOSIS; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE FIBROSIS; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SARCOIDOSIS; SCLERODERMA;

AGED; FEMALE; FIBROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; SCLERODERMA, DIFFUSE;

EID: 33646681442     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc053128     Document Type: Letter

References (5)

1. Fowles RE, Mason JW. Endomyocardial biopsy. Ann Intern Med 1982;97:885-94.
2. Beller GA. Noninvasive assessment of myocardial viability. N Engl J Med 2000;343:1488-90.
3. Kwong RY, Falk RH. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:122-4.
4. Smedema JP, Snoep G, van Kroonenburgh MP, et al. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 2005;128:1629-37.
5. Serra JJ, Monte GU, Mello ES, et al. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging. Circulation 2003;107:e188-e189.